Long-term follow-up and late complications of CAR-T cell therapy
Background: Chimeric antigen receptor T-cell (CAR-T cell) therapy has transformed the treatment landscape for relapsed or refractory hematologic malignancies. As the number of long-term survivors continues to grow, the recognition and management of late complications have become critical clinical priorities. The existing literature remains fragmented, with limited long-term prospective data and a lack of unified follow-up guidelines. Methods: A narrative review of the literature was conducted using PubMed, MEDLINE, and Google Scholar databases from inception through April 2026. Key search terms included long-term follow-up, survivorship, late effects, CAR-T cell therapy, chimeric antigen receptor, late complications, delayed cytopenias, hypogammaglobulinemia, secondary malignancies, immune reconstitution, and screening. This review synthesizes available evidence with expert consensus recommendations. Results: The review identifies prolonged cytopenias, hypogammaglobulinemia and infectious complications as the most prevalent late effects. Secondary myeloid neoplasms occur with a shorter latency than historically observed after conventional chemotherapy. Neurocognitive deficits following immune effector cell-associated neurotoxicity syndrome generally resolve within six months. Cardiovascular, endocrine, and reproductive late effects are emerging areas of concern with limited specific data. Conclusion: Structured, long-term, multidisciplinary follow-up is essential for CAR-T cell therapy recipients. This review provides recommendations for the long-term surveillance and management of these patients. Prospective registries and standardized screening protocols are urgently needed.
Authors
- Karine Sampaio Nunes Barroso (ORCID: https://orcid.org/0000-0002-5346-9414)
- Giancarlo Fatobene (ORCID: https://orcid.org/0000-0003-4145-049X)
Institutions
- Universidade de São Paulo (BR)
- Hospital Universitário Walter Cantídio (BR)
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
Publication Details
- Journal
- JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY
- Published
- 2026-11-20
- DOI
- https://doi.org/10.46765/2675-374x.2025v7n1e333
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00